Eris Lifesciences reports Q4FY21 consolidated net profit of Rs. 68.24 Cr
Chemical

Eris Lifesciences reports Q4FY21 consolidated net profit of Rs. 68.24 Cr

Eris Lifesciences has reported total income of Rs.1220.57 crores during the 12 months period ended March 31, 2021

  • By ICN Bureau | May 13, 2021

Eris Lifesciences Ltd has reported total income of Rs.280.41 crores during the period ended March 31, 2021 as compared to Rs.313.49 crores during the period ended December 31, 2020. It reported total income of Rs.247.5 crores during the period ended March 31, 2020. 

The company has posted net profit of Rs.68.24 crores for the period ended March 31, 2021 as against net profit of Rs.90.15 crores for the period ended December 31, 2020. It posted net profit of Rs.56.27 crores for the period ended March 31, 2020.

Eris Lifesciences has reported total income of Rs.1220.57 crores during the 12 months period ended March 31, 2021 as compared to Rs.1089.45 crores during the 12 months period ended March 31, 2020.

Eris Lifesciences has posted net profit of Rs.355.13 crores for the 12 months period ended March 31, 2021 as against net profit of Rs.296.50 crores for the 12 months period ended March 31, 2020.

Register Now to Attend E-Conference on Digital Transformation: The Catalyst for Agile and Smarter Process R&D on June 4 at 3:00 - 4:30 PM IST

Register Now to Attend NextGen Chemicals & Petrochemicals Summit 2025 on June 18-19th 2025, The Leela Mumbai

Other Related stories

Startups

Petrochemical

Energy

Digitization